BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma

被引:35
作者
Paoluzzi, Luca [1 ,2 ,3 ]
Hanniford, Douglas [2 ,3 ]
Sokolova, Elena [2 ,3 ]
Osman, Iman [2 ,3 ,4 ]
Darvishian, Farbod [3 ]
Wang, Jinhua [1 ,3 ,5 ]
Bradner, James E. [6 ]
Hernando, Eva [2 ,3 ]
机构
[1] NYU, Langone Med Ctr, Inst Canc, 550 First Ave,SML 305, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Pathol, New York, NY USA
[3] NYU, Interdisciplinary Melanoma Cooperat Grp, Inst Canc, Langone Med Ctr, New York, NY USA
[4] NYU, Sch Med, Dept Dermatol, New York, NY USA
[5] NYU, Ctr Hlth Informat & Bioinformat, New York, NY USA
[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
基金
美国国家卫生研究院;
关键词
BET inhibition; BRAF inhibition; JQ1; Melanoma; Vemurafenib; SELECTIVE-INHIBITION; METASTATIC MELANOMA; MEDIATED APOPTOSIS; TARGET; CELLS; BRD4; EXPRESSION;
D O I
10.1002/cam4.667
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite major advances in the treatment of metastatic melanoma, treatment failure is still inevitable in most cases. Manipulation of key epigenetic regulators, including inhibition of Bromodomain and extra-terminal domain (BET) family members impairs cell proliferation in vitro and tumor growth in vivo in different cancers, including melanoma. Here, we investigated the effect of combining the BET inhibitor JQ1 with the BRAF inhibitor Vemurafenib in in vitro and in vivo models of BRAF-mutant melanoma. We performed cytotoxicity and apoptosis assays, and a xenograft mouse model to determine the in vitro and in vivo efficacy of JQ1 in combination with Vemurafenib against BRAF-mutant melanoma cell lines. Further, to investigate the molecular mechanisms underlying the effects of combined treatment, we conducted antibody arrays of in vitro drug-treated cell lines and RNA sequencing of drug-treated xenograft tumors. The combination of JQ1 and Vemurafenib acted synergistically in BRAF-mutant cell lines, resulting in marked apoptosis in vitro, with upregulation of proapoptotic proteins. In vivo, combination treatment suppressed tumor growth and significantly improved survival compared to either drug alone. RNA sequencing of tumor tissues revealed almost four thousand genes that were uniquely modulated by the combination, with several anti-apoptotic genes significantly down-regulated. Collectively, our data provide a rationale for combined BET and BRAF inhibition as a novel strategy for the treatment of melanoma.
引用
收藏
页码:1183 / 1193
页数:11
相关论文
共 33 条
[1]   Born to be alive: a role for the BCL-2 family in melanoma tumor cell survival, apoptosis, and treatment [J].
Anvekar, Rina A. ;
Asciolla, James J. ;
Missert, Derek J. ;
Chipuk, Jerry E. .
FRONTIERS IN ONCOLOGY, 2011, 1
[2]   Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway [J].
Atefi, Mohammad ;
von Euw, Erika ;
Attar, Narsis ;
Ng, Charles ;
Chu, Connie ;
Guo, Deliang ;
Nazarian, Ramin ;
Chmielowski, Bartosz ;
Glaspy, John A. ;
Comin-Anduix, Begonya ;
Mischel, Paul S. ;
Lo, Roger S. ;
Ribas, Antoni .
PLOS ONE, 2011, 6 (12)
[3]   Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway [J].
Bandyopadhyay, D ;
Mishra, A ;
Medrano, EE .
CANCER RESEARCH, 2004, 64 (21) :7706-7710
[4]   Vemurafenib Potently Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in BRAFV600E Melanoma Cells [J].
Beck, Daniela ;
Niessner, Heike ;
Smalley, Keiran S. M. ;
Flaherty, Keith ;
Paraiso, Kim H. T. ;
Busch, Christian ;
Sinnberg, Tobias ;
Vasseur, Sophie ;
Iovanna, Juan Lucio ;
Driessen, Stefan ;
Stork, Bjoern ;
Wesselborg, Sebastian ;
Schaller, Martin ;
Biedermann, Tilo ;
Bauer, Juergen ;
Lasithiotakis, Konstantinos ;
Weide, Benjamin ;
Eberle, Juergen ;
Schittek, Birgit ;
Schadendorf, Dirk ;
Garbe, Claus ;
Kulms, Dagmar ;
Meier, Friedegund .
SCIENCE SIGNALING, 2013, 6 (260)
[5]   A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma [J].
Bhandaru, Madhuri ;
Ardekani, Gholamreza Safaee ;
Zhang, Guohong ;
Martinka, Magdalena ;
McElwee, Kevin J. ;
Li, Gang ;
Rotte, Anand .
BMC CANCER, 2014, 14
[6]   A potent Chkl inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress [J].
Brooks, K. ;
Oakes, V. ;
Edwards, B. ;
Ranall, M. ;
Leo, P. ;
Pavey, S. ;
Pinder, A. ;
Beamish, H. ;
Mukhopadhyay, P. ;
Lambie, D. ;
Gabrielli, B. .
ONCOGENE, 2013, 32 (06) :788-796
[7]   Bromodomain 4 activation predicts breast cancer survival [J].
Crawford, Nigel P. S. ;
Alsarraj, Jude ;
Lukes, Luanne ;
Walker, Renard C. ;
Officewala, Jennifer S. ;
Yang, Howard H. ;
Lee, Maxwell P. ;
Ozato, Keiko ;
Hunter, Kent W. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (17) :6380-6385
[8]   PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies [J].
De Raedt, Thomas ;
Beert, Eline ;
Pasmant, Eric ;
Luscan, Armelle ;
Brems, Hilde ;
Ortonne, Nicolas ;
Helin, Kristian ;
Hornick, Jason L. ;
Mautner, Victor ;
Kehrer-Sawatzki, Hildegard ;
Clapp, Wade ;
Bradner, James ;
Vidaud, Michel ;
Upadhyaya, Meena ;
Legius, Eric ;
Cichowski, Karen .
NATURE, 2014, 514 (7521) :247-+
[9]   BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc [J].
Delmore, Jake E. ;
Issa, Ghayas C. ;
Lemieux, Madeleine E. ;
Rahl, Peter B. ;
Shi, Junwei ;
Jacobs, Hannah M. ;
Kastritis, Efstathios ;
Gilpatrick, Timothy ;
Paranal, Ronald M. ;
Qi, Jun ;
Chesi, Marta ;
Schinzel, Anna C. ;
McKeown, Michael R. ;
Heffernan, Timothy P. ;
Vakoc, Christopher R. ;
Bergsagel, P. Leif ;
Ghobrial, Irene M. ;
Richardson, Paul G. ;
Young, Richard A. ;
Hahn, William C. ;
Anderson, Kenneth C. ;
Kung, Andrew L. ;
Bradner, James E. ;
Mitsiades, Constantine S. .
CELL, 2011, 146 (06) :903-916
[10]   Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes [J].
Di Micco, Raffaella ;
Fontanals-Cirera, Barbara ;
Low, Vivien ;
Ntziachristos, Panagiotis ;
Yuen, Stephanie K. ;
Lovell, Claudia D. ;
Dolgalev, Igor ;
Yonekubo, Yoshiya ;
Zhang, Guangtao ;
Rusinova, Elena ;
Gerona-Navarro, Guillermo ;
Canamero, Marta ;
Ohlmeyer, Michael ;
Aifantis, Iannis ;
Zhou, Ming-Ming ;
Tsirigos, Aristotelis ;
Hernando, Eva .
CELL REPORTS, 2014, 9 (01) :234-247